PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323,466 | -40.1% | 38,741 | -4.5% | 0.00% | -100.0% |
| Q2 2023 | $539,739 | +11.8% | 40,575 | -2.8% | 0.00% | 0.0% |
| Q1 2023 | $482,773 | +59.5% | 41,723 | +12.8% | 0.00% | 0.0% |
| Q4 2022 | $302,717 | +320.4% | 36,978 | +199.9% | 0.00% | – |
| Q3 2022 | $72,000 | +38.5% | 12,330 | +5.9% | 0.00% | – |
| Q2 2022 | $52,000 | -97.2% | 11,640 | -21.6% | 0.00% | -100.0% |
| Q1 2022 | $1,854,000 | +520.1% | 14,852 | +2.3% | 0.00% | +300.0% |
| Q4 2021 | $299,000 | +38.4% | 14,522 | +71.4% | 0.00% | – |
| Q3 2021 | $216,000 | -23.9% | 8,472 | +5.0% | 0.00% | -100.0% |
| Q2 2021 | $284,000 | +10.1% | 8,072 | +4.2% | 0.00% | 0.0% |
| Q1 2021 | $258,000 | +109.8% | 7,743 | +64.2% | 0.00% | – |
| Q4 2020 | $123,000 | – | 4,715 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |